GGrantIndex
Sort

46,585 grants matching heart failure

A Targeted Approach to Treat Immunotherapy-Induced Myocarditis with CXCR3 Blockade

$773,843
Han Zhu · Stanford University · R01 · FY2025 · HL

Hypergen: Genetics of Left Ventricular Hypertrophy

$773,784
Donna K. Arnett · University Of Alabama At Birmingham · R01 · FY2009 · HL

Dimensions of Kidney Tubule Health and Atherosclerotic Cardiovascular Disease and Heart Failure in Middle-Aged and Older Adults

$773,777
Mark J Sarnak · Tufts Medical Center · R01 · FY2023 · HL

Cardiac MRI Increases Accuracy and Decreases Risk of Evaluation of Children with Cardiomyopathy and Cardiac Transplantation

$773,729
Laura J Olivieri · Children'S Research Institute · R01 · FY2019 · HL

Development and Pre-Clinical Trial Qualification of a Pediatric Pump-Lung System for Children

$773,727
Bartley Perry Griffith · University Of Maryland Baltimore · R01 · FY2020 · HL

Elucidating the structural insights into the BMP receptor mutations in PAH

$773,673
Akiko Hata · University Of California, San Francisco · R01 · FY2024 · HL

Childhood Hypertension and Obesity: Diagnosis, Care, and Costs

$773,654
Patrick J O'Connor · Healthpartners Institute · R01 · FY2009 · HL

Genetics and Mechanisms of Mitral Valve Prolapse

$773,633
David J Milan · Massachusetts General Hospital · R01 · FY2015 · HL

Pragmatic collaborative care for cardiac inpatients with depression or anxiety

$773,503
Jeff C Huffman · Massachusetts General Hospital · R01 · FY2017 · HL

Translation of novel and repurposed drugs to address the acute and late effects of mustard exposure

$773,440
Kurt Lu · Northwestern University At Chicago · U01 · FY2021 · AR

Novel Pre-Hospital Therapy of Myocardial Infarction

$773,382
Asaf Alimardanov · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR

Ultrasound-mediated Controlled Hypoxemic Reperfusion for Inhibition of Reperfusion Injury

$773,375
Kevin Joseph Haworth · University Of Cincinnati · R01 · FY2019 · HL

Nanostructuring and Molecular Imaging of Engineered Cardiovascular Tissues

$773,367
Joseph C Wu · Stanford University · R33 · FY2010 · HL

Understanding the Cardiac Benefits of Exercise at the Cellular and Molecular Level

$773,364
Anthony Rosenzweig · University Of Michigan At Ann Arbor · R35 · FY2025 · HL

Biomarker Collection and Analysis in the PRESERVE Trial Cohort

$773,226
Steven Weisbord · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · DK

Improving treatment of cardiovascular risk factors in childhood cancer survivors

$773,174
Eric Jessen Chow · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA

AFGen Consortium: Atrial Fibrillation Genomics to Functional Analyses

$773,155
Emelia J. Benjamin · Boston University Medical Campus · R01 · FY2017 · HL

Structural Dynamics of Cardiac Muscle Calcium ATPase Regulation

$773,075
David Dale Thomas · University Of Minnesota · R01 · FY2023 · HL

Structural Dynamics of Cardiac Muscle Calcium ATPase Regulation

$773,075
David Dale Thomas · University Of Minnesota · R01 · FY2022 · HL

Deacetylase-Dependent Control of Diastolic Dysfunction and HFpEF

$773,007
Timothy McKinsey · University Of Colorado Denver · R01 · FY2020 · HL

The Efficacy and Safety of a Selective Estrogen Receptor Beta agonist (LY500307)

$772,935
Alan Breier · Indiana University Indianapolis · UH3 · FY2016 · TR

Metabolic pathways in cardiac physiology and heart failure

$772,808
John William Elrod · Temple Univ Of The Commonwealth · R01 · FY2025 · HL

Myocardial Tissue Characterization with MR Relaxometry in Heart Failure

$772,801
Reza Nezafat · Beth Israel Deaconess Medical Center · R01 · FY2018 · HL

Predictors of CVD among breast cancer survivors in an integrated health system

$772,793
Marilyn L Kwan · Kaiser Foundation Research Institute · R01 · FY2018 · CA

Molecular Characterization of Progressive Pulmonary Sarcoidosis

$772,729
Lisa A Maier · National Jewish Health · R01 · FY2024 · HL